MS

FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thu, 10/22/09 - 09:14 am
Acorda Therapeutics
FDA
MS
multiple sclerosis
Fampridine-SR
Elan pins hopes on multiple sclerosis drug
FT.com
Wed, 10/21/09 - 09:22 am
Elan
MS
multiple sclerosis
Tysabri
JNJ
Avanir, Acorda move on MS drug updates
Market Watch
Sat, 10/10/09 - 12:38 pm
Avanir
Acorda Therapeutics
MS
Drug stocks mixed; Avanir jumps on MS news
Marketwatch
Fri, 10/9/09 - 10:08 am
Avanir
MS
drug stocks
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Fri, 10/9/09 - 09:30 am
Acorda Therapeutics
MS
multiple sclerosis
Fampridine-SR
Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Bloomberg
Wed, 10/7/09 - 08:41 am
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Why I'm Invested in Tysabri and Elan
Motley Fool
Thu, 10/1/09 - 04:17 pm
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
More Questions Than Answers From Elan
Motley Fool
Wed, 09/30/09 - 06:08 pm
Elan
Biogen Idec
Tysabri
MS
multiple sclerosis
Good News for Novartis
Yahoo/Zacks.com
Wed, 09/30/09 - 09:51 am
Novartis
MS
multiple sclerosis
US regulators subpoena documents of brain disease with drugmaker Elan's Tysabri
Yahoo/AP
Wed, 09/30/09 - 06:50 am
Elan
Tysabri
PML
Biogen Idec
MS
multiple sclerosis
FDA says it confirmed new cases of brain inflammation linked to MS drug, bringing total to 13
Yahoo/AP
Tue, 09/22/09 - 10:44 am
FDA
PML
Tysabri
MS
Biogen Idec
Elan
Genzyme's MS Drug Shows Promise
Seeking Alpha
Fri, 09/18/09 - 11:21 am
Genzyme
multiple sclerosis
MS
alemtuzumab
Acorda Therapeutics cites additional positive safety data on multiple sclerosis drug
Yahoo/AP
Tue, 09/15/09 - 07:47 pm
Acorda Therapeutics
multiple sclerosis
MS
Fampridine-SR
Teva: MS drug Laquinimod works two ways
Globes, Israel
Sun, 09/13/09 - 12:52 pm
laquinimod
Teva Pharmaceuticals
MS
multiple sclerosis
Merck KGaA pulls ahead in hot oral MS drug race
Fierce Biotech
Fri, 09/11/09 - 09:22 am
Merck KGaA
multiple sclerosis
MS
MS drug Tysabri reawakens brain virus -study
Forbes/Reuters
Thu, 09/10/09 - 11:31 am
MS
Tysabri
Elan
Biogen Idec
PML
multiple sclerosis
Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis
Yahoo
Tue, 09/8/09 - 07:40 am
Opexa
MS
multiple sclerosis
Tovaxin
Adeona Prepares Three Drugs for NDA Submission
Offical Wire
Fri, 09/4/09 - 07:46 am
NDA
FDA
Adeona
Trimesta
MS
Zinthionein
macular degeneration
JP1
rheumatoid arthritis
Acorda confirms FDA panel review date for MS drug
Yahoo/AP
Tue, 08/25/09 - 12:22 pm
Acorda Therapeutics
MS
FDA
multiple sclerosis
Fampridine-SR
Novartis’s Big Plans for Multiple Sclerosis
WSJ Online
Mon, 08/17/09 - 11:29 am
Novartis
MS
multiple sclerosis
Bayer

Pages